COMMUNIQUÉS West-GlobeNewswire
-
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
18/06/2026 -
Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators
18/06/2026 -
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
18/06/2026 -
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
18/06/2026 -
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
18/06/2026 -
Breckenridge Distillery Releases Limited Single Barrel Bourbon Collection
18/06/2026 -
Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering
18/06/2026 -
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
18/06/2026 -
VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026
18/06/2026 -
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
18/06/2026 -
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”
18/06/2026 -
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
18/06/2026 -
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
18/06/2026 -
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
18/06/2026 -
Court victory paves the way for Curium’s plans to provide targeted radioligand therapy to U.S. patients with GEP-NETs
18/06/2026 -
Routine Eye Exams Help Portsmouth and Seacoast Residents Monitor Vision and Eye Health
18/06/2026 -
Essential Pharma appoints Becki Morison as Chief Executive Officer
18/06/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
18/06/2026 -
Halberd Corporation Ships Latest NeuroSense AI Version, Advancing Voice-Based Behavioral Monitoring
18/06/2026
Pages